In a January 2026 article, Freeflow Ventures featured Izote alongside four other Berkeley-connected companies in its portfolio.
The feature discusses the role of scientific founders in turning research into companies that address substantial technical challenges. Its discussion of Izote focuses on the economics of biomanufacturing and the potential of alternative microbial respiration.
Freeflow is an investor in Izote. The article offers its perspective on the scientific foundation of the company and the industrial opportunity it is pursuing.